Securing a reliable source for highly specialized veterinary pharmaceuticals and animal recovery formulations can be a complex endeavor. Facilities require precise, customized solutions—often encompassing specific antigens, peptides, and advanced pharmaceutical preparations—to ensure optimal animal health and seamless operational flow. When standard market offerings fail to meet strict dosage, stability, or species-specific requirements, the search for a qualified manufacturing partner becomes critical to avoiding costly supply chain disruptions and compromised care.
Established in 2008, Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. serves as the definitive answer to this challenge. As a premier China/Custom lie down factory, the facility spans a massive 21,000 square meters in Xinle City's East Industrial Park. By successfully passing the rigorous acceptance of the new veterinary drug GMP of the Ministry of Agriculture in 2022, the enterprise guarantees that every custom batch meets elite global safety and efficacy standards. Integrating R&D, production, sales, and service, the company eliminates the friction of sourcing complex pet, poultry, and livestock medicines, providing a streamlined pathway from custom formulation to final delivery.
Delivering high-performance veterinary solutions requires uncompromising technical rigor. From formulating specialized antiparasitics like Ivermectin to stabilizing advanced probiotics such as Bacillus Coagulans SNZ 1969, the infrastructure behind the manufacturing process dictates the final product's viability. A top-tier manufacturing partner must balance high-volume capabilities with micro-level precision.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Regulatory Compliance | Ensures product safety, legal market entry, and consistency across batches. | Certified under the 2022 Ministry of Agriculture New Veterinary Drug GMP. | Unquestionable regulatory alignment for both domestic and international distribution. |
| Production Capacity | Secures supply chain stability against market fluctuations. | 21,000 sqm facility processing over 100 varieties of veterinary formulations. | Scalable fulfillment capable of rapid response to large-volume demands. |
| Formulation Versatility | Allows for targeted treatments across diverse species (aquarium, poultry, pets). | Advanced lines for powders, premixes, oral solutions, and mixed feed additives. | End-to-end customized product development tailored to specific physiological needs. |
| Global Accessibility | Facilitates smooth cross-border trade and localized technical support. | Multilingual support network encompassing Arabic, French, German, Russian, and Spanish. | Frictionless communication and seamless integration into global markets. |
By leveraging specific antigens and tailored pharmaceutical guides (such as targeted Salpingitis Bilateral treatments), this infrastructure ensures that every formulation exiting the facility is engineered for maximum bioavailability and therapeutic success.
Strategic procurement is no longer just about cost-cutting; it is about value engineering. Partnering with a comprehensive China/Custom lie down factory transforms raw material acquisition into a competitive advantage. Because Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. controls the entire lifecycle—from raw material sourcing of peptides and probiotics to the final production of liquid mixed feed additives—clients experience significantly reduced lead times and minimized middleman markups.
This vertical integration directly correlates to long-term financial gains. With a broad international market reach and a diverse portfolio of over 100 varieties, investing in custom manufacturing here means securing a future-proof supply chain that scales alongside your global expansion efforts.
Related products
Top Selling Products
